Details of the Drug

General Information of Drug (ID: DMNHLO5)

Drug Name

225Ac-labelled FPX-01

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Radiopharmaceutical therapy agent

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03746431) A Phase 1 Study of [225Ac]-FPI-1434 Injection. U.S. National Institutes of Health.